1
Clinical Trials associated with VRP adjuvant vaccination(Global Vaccines, Inc.) / CompletedNot ApplicableIIT Phase I/II study of VEGFR1/2-derived peptide vaccination in combination with a 5-fluorouracil derivative (TS-1) for metastatic colorectal cancer with KRAS genetic mutation as a third-line therapy - Phase I/II study of peptide vaccination in combination with TS-1 for metastatic colorectal cancer with KRAS genetic mutation
Start Date01 Dec 2009 |
Sponsor / Collaborator- |
100 Clinical Results associated with VRP adjuvant vaccination(Global Vaccines, Inc.)
100 Translational Medicine associated with VRP adjuvant vaccination(Global Vaccines, Inc.)
100 Patents (Medical) associated with VRP adjuvant vaccination(Global Vaccines, Inc.)
100 Deals associated with VRP adjuvant vaccination(Global Vaccines, Inc.)